Literature DB >> 15331735

Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes.

Gabriele Hahn1, Maria Grazia Revello, Marco Patrone, Elena Percivalle, Giulia Campanini, Antonella Sarasini, Markus Wagner, Andrea Gallina, Gabriele Milanesi, Ulrich Koszinowski, Fausto Baldanti, Giuseppe Gerna.   

Abstract

Human cytomegalovirus (HCMV), a ubiquitous human pathogen, is the leading cause of birth defects and morbidity in immunocompromised patients and a potential trigger for vascular disease. HCMV replicates in vascular endothelial cells and drives leukocyte-mediated viral dissemination through close endothelium- leukocyte interaction. However, the genetic basis of HCMV growth in endothelial cells and transfer to leukocytes is unknown. We show here that the UL131-128 gene locus of HCMV is indispensable for both productive infection of endothelial cells and transmission to leukocytes. The experimental evidence for this is based on both the loss-of-function phenotype in knockout mutants and natural variants and the gain-of-function phenotype by trans-complementation with individual UL131, UL130, and UL128 genes. Our findings suggest that a common mechanism of virus transfer may be involved in both endothelial cell tropism and leukocyte transfer and shed light on a crucial step in the pathogenesis of HCMV infection. Copyright 2004 American Society for Microbiology

Entities:  

Mesh:

Year:  2004        PMID: 15331735      PMCID: PMC515016          DOI: 10.1128/JVI.78.18.10023-10033.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Human cytomegalovirus replicates abortively in polymorphonuclear leukocytes after transfer from infected endothelial cells via transient microfusion events.

Authors:  G Gerna; E Percivalle; F Baldanti; S Sozzani; P Lanzarini; E Genini; D Lilleri; M G Revello
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  A ribonucleotide reductase homolog of cytomegalovirus and endothelial cell tropism.

Authors:  W Brune; C Ménard; J Heesemann; U H Koszinowski
Journal:  Science       Date:  2001-01-12       Impact factor: 47.728

3.  Efficient lytic infection of human arterial endothelial cells by human cytomegalovirus strains.

Authors:  M Kahl; D Siegel-Axel; S Stenglein; G Jahn; C Sinzger
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

4.  Murine cytomegalovirus CC chemokine homolog MCK-2 (m131-129) is a determinant of dissemination that increases inflammation at initial sites of infection.

Authors:  N Saederup; S A Aguirre; T E Sparer; D M Bouley; E S Mocarski
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

5.  The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration.

Authors:  D N Streblow; C Soderberg-Naucler; J Vieira; P Smith; E Wakabayashi; F Ruchti; K Mattison; Y Altschuler; J A Nelson
Journal:  Cell       Date:  1999-11-24       Impact factor: 41.582

Review 6.  A review of genetic differences between limited and extensively passaged human cytomegalovirus strains.

Authors:  M N Prichard; M E Penfold; G M Duke; R R Spaete; G W Kemble
Journal:  Rev Med Virol       Date:  2001 May-Jun       Impact factor: 6.989

7.  In vitro selection of human cytomegalovirus variants unable to transfer virus and virus products from infected cells to polymorphonuclear leukocytes and to grow in endothelial cells.

Authors:  M Grazia Revello; Fausto Baldanti; Elena Percivalle; Antonella Sarasini; Luciana De-Giuli; Emilia Genini; Daniele Lilleri; Nazarena Labò; Giuseppe Gerna
Journal:  J Gen Virol       Date:  2001-06       Impact factor: 3.891

8.  In silico structural and functional analysis of the human cytomegalovirus (HHV5) genome.

Authors:  J Novotny; I Rigoutsos; D Coleman; T Shenk
Journal:  J Mol Biol       Date:  2001-07-27       Impact factor: 5.469

9.  Tropism of human cytomegalovirus for endothelial cells is determined by a post-entry step dependent on efficient translocation to the nucleus.

Authors:  C Sinzger; M Kahl; K Laib; K Klingel; P Rieger; B Plachter; G Jahn
Journal:  J Gen Virol       Date:  2000-12       Impact factor: 3.891

Review 10.  Do pathogens accelerate atherosclerosis?

Authors:  D N Streblow; S L Orloff; J A Nelson
Journal:  J Nutr       Date:  2001-10       Impact factor: 4.798

View more
  268 in total

1.  Role of human cytomegalovirus genotype polymorphisms in AIDS patients with cytomegalovirus retinitis.

Authors:  Jens-Uwe Vogel; Jürgen Otte; Frank Koch; Hermann Gümbel; Hans Wilhelm Doerr; Jindrich Cinatl
Journal:  Med Microbiol Immunol       Date:  2012-06-06       Impact factor: 3.402

Review 2.  Human cytomegalovirus infection and atherothrombosis.

Authors:  Milan Popović; Katarina Smiljanić; Branislava Dobutović; Tatiana Syrovets; Thomas Simmet; Esma R Isenović
Journal:  J Thromb Thrombolysis       Date:  2012-02       Impact factor: 2.300

3.  RASCAL is a new human cytomegalovirus-encoded protein that localizes to the nuclear lamina and in cytoplasmic vesicles at late times postinfection.

Authors:  Matthew S Miller; Wendy E Furlong; Leesa Pennell; Marc Geadah; Laura Hertel
Journal:  J Virol       Date:  2010-04-14       Impact factor: 5.103

4.  Identification of TRIM23 as a cofactor involved in the regulation of NF-kappaB by human cytomegalovirus.

Authors:  Emma Poole; Ian Groves; Andrew MacDonald; Yin Pang; Antonio Alcami; John Sinclair
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

5.  Development of a high-throughput assay to measure the neutralization capability of anti-cytomegalovirus antibodies.

Authors:  Thomas J Gardner; Cynthia Bolovan-Fritts; Melissa W Teng; Veronika Redmann; Thomas A Kraus; Rhoda Sperling; Thomas Moran; William Britt; Leor S Weinberger; Domenico Tortorella
Journal:  Clin Vaccine Immunol       Date:  2013-02-06

6.  Human cytomegalovirus and human immunodeficiency virus type-1 co-infection in human cervical tissue.

Authors:  Andrea M Fox-Canale; Thomas J Hope; Jeffrey Martinson; John R Lurain; Alfred W Rademaker; James W Bremer; Alan Landay; Gregory T Spear; Nell S Lurain
Journal:  Virology       Date:  2007-08-22       Impact factor: 3.616

7.  Developing a Vaccine against Congenital Cytomegalovirus (CMV) Infection: What Have We Learned from Animal Models? Where Should We Go Next?

Authors:  Mark R Schleiss
Journal:  Future Virol       Date:  2013-12       Impact factor: 1.831

8.  Coding potential of UL/b' from the initial source of rhesus cytomegalovirus Strain 68-1.

Authors:  Rachel B Gill; J Jason Bowman; Tammy Krogmann; Kurt Wollenberg; David M Asher; Jeffrey I Cohen
Journal:  Virology       Date:  2013-10-02       Impact factor: 3.616

9.  Platelet-derived growth factor-α receptor is the cellular receptor for human cytomegalovirus gHgLgO trimer.

Authors:  Anna Kabanova; Jessica Marcandalli; Tongqing Zhou; Siro Bianchi; Ulrich Baxa; Yaroslav Tsybovsky; Daniele Lilleri; Chiara Silacci-Fregni; Mathilde Foglierini; Blanca Maria Fernandez-Rodriguez; Aliaksandr Druz; Baoshan Zhang; Roger Geiger; Massimiliano Pagani; Federica Sallusto; Peter D Kwong; Davide Corti; Antonio Lanzavecchia; Laurent Perez
Journal:  Nat Microbiol       Date:  2016-06-06       Impact factor: 17.745

10.  Restriction of Human Cytomegalovirus Infection by Galectin-9.

Authors:  Allison Abendroth; Brian P McSharry; Barry Slobedman; Emily A Machala; Selmir Avdic; Lauren Stern; Dirk M Zajonc; Chris A Benedict; Emily Blyth; David J Gottlieb
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.